{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T02:08:32Z","timestamp":1783908512419,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Natural Science Foundation of China for Young Scientists","award":["No. 82505550"],"award-info":[{"award-number":["No. 82505550"]}]},{"name":"the 2023 Key Discipline Construction of High-level Traditional Chinese Medicine by the National Administration of Traditional Chinese Medicine","award":["No. Zyyzdxk-2023210"],"award-info":[{"award-number":["No. Zyyzdxk-2023210"]}]},{"name":"the Key Research and Development Program of Ningxia Hui Autonomous Region","award":["No. 2019BFG2021"],"award-info":[{"award-number":["No. 2019BFG2021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00210-026-05210-2","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T02:02:12Z","timestamp":1774663332000},"page":"13569-13588","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gut microbiota and metabolomic alterations underlying the therapeutic effects of SQJZ capsules in a rat model of chronic renal failure"],"prefix":"10.1007","volume":"399","author":[{"given":"Rui","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianwen","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anrong","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"5210_CR1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-23-0195","author":"R-G Alba","year":"2023","unstructured":"Alba R-G, Andr\u00e9s A, Roberto G-V, Mar\u00eda Luz M, Rub\u00e9n G-G, Pablo J, Clara C, Jos\u00e9 S-P, Nieves L, Rafael A, Noem\u00ed P, Mar\u00eda-Victoria M, Rosa A, Dulcenombre G-G, Joaqu\u00edn M-L, Mar\u00eda L (2023) Short-chain fatty acid production by gut microbiota predicts treatment response in multiple myeloma. Clin Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-23-0195","journal-title":"Clin Cancer Res"},{"key":"5210_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq818","author":"M Bj\u00f6rn K I","year":"2011","unstructured":"Bj\u00f6rn K I M, Pieter E (2011) The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfq818","journal-title":"Nephrol Dial Transplant"},{"issue":"02","key":"5210_CR3","first-page":"313","volume":"38","author":"M Chen","year":"2016","unstructured":"Chen M, Ni Z, Liu YN, Xie YS, Sun W (2016) Guidelines for the integrated Traditional Chinese and Western medicine treatment of chronic renal failure. Hebei Traditional Chinese Medicine 38(02):313\u2013317","journal-title":"Hebei Traditional Chinese Medicine"},{"key":"5210_CR4","unstructured":"Clase C (2011) Renal failure (chronic). BMJ Clin Evid\u00a02011. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21609509"},{"issue":"3","key":"5210_CR5","doi-asserted-by":"publisher","first-page":"iii35","DOI":"10.1093\/ndt\/gfy175","volume":"33","author":"G Cobo","year":"2018","unstructured":"Cobo G, Lindholm B, Stenvinkel P (2018) Chronic inflammation in end-stage renal disease and dialysis. Nephrol Dial Transplant 33(3):iii35\u2013iii40. https:\/\/doi.org\/10.1093\/ndt\/gfy175","journal-title":"Nephrol Dial Transplant"},{"key":"5210_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116257","author":"H Cong","year":"2023","unstructured":"Cong H, Zhen S, Tao C, Shan-Shan A, Ran-Ran G, Yao L, Gui-Yuan S, Hong-Zhen H, Wei L (2023) Yi-Shen-Hua-Shi granule ameliorates diabetic kidney disease by the \u201cgut-kidney axis.\u201d J Ethnopharmacol. https:\/\/doi.org\/10.1016\/j.jep.2023.116257","journal-title":"J Ethnopharmacol"},{"issue":"11","key":"5210_CR7","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s00467-016-3527-x","volume":"32","author":"P Evenepoel","year":"2017","unstructured":"Evenepoel P, Poesen R, Meijers B (2017) The gut-kidney axis. Pediatr Nephrol 32(11):2005\u20132014. https:\/\/doi.org\/10.1007\/s00467-016-3527-x","journal-title":"Pediatr Nephrol"},{"key":"5210_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105354","author":"M Giorgia","year":"2022","unstructured":"Giorgia M, Pasquale M, Biagio Raffaele DI, August H, Stefania M (2022) Short-chain fatty acids in chronic kidney disease: focus on inflammation and oxidative stress regulation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23105354","journal-title":"Int J Mol Sci"},{"key":"5210_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0300705","author":"L Hong","year":"2024","unstructured":"Hong L, Kang S (2024) Elucidating ascorbate and aldarate metabolism pathway characteristics via integration of untargeted metabolomics and transcriptomics of the kidney of high-fat diet-fed obese mice. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0300705","journal-title":"PLoS One"},{"key":"5210_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.112858","author":"C Hong","year":"2020","unstructured":"Hong C, Qing L, Wan-Fu B, Ying-Chun B, Xiao-Ye J, Chen G, Quan-Li L, Song-Li S, Hong-Bing Z (2020) Protective effects of Amygdalus mongolica on rats with renal fibrosis based on serum metabolomics. J Ethnopharmacol. https:\/\/doi.org\/10.1016\/j.jep.2020.112858","journal-title":"J Ethnopharmacol"},{"key":"5210_CR11","first-page":"12","volume":"05","author":"A Hu","year":"2010","unstructured":"Hu A, Zhu X, Yuan H (2010) Establishment and evaluation of chronic renal failure rat model. Shanghai J Anim Husbandry Vet Med 05:12\u201313","journal-title":"Shanghai J Anim Husbandry Vet Med"},{"key":"5210_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/nu12092799","author":"W I-Wen","year":"2020","unstructured":"I-Wen W, Chin-Chan L, Heng-Jung H, Chiao-Yin S, Yuen-Chan C, Kai-Jie Y, Chi-Wei Y, Wen-Hun C, Hsin-Chih L, Lun-Ching C, Shih-Chi S (2020) Compositional and functional adaptations of intestinal microbiota and related metabolites in CKD patients receiving dietary protein restriction. Nutrients. https:\/\/doi.org\/10.3390\/nu12092799","journal-title":"Nutrients"},{"key":"5210_CR13","doi-asserted-by":"publisher","unstructured":"J\u00f6rg C S, Jan-Philip Z, Christina F, Stephan v, Rene P, Dietrich H, Hans-Dieter V, Christine S, Petra R (2009) Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfn739","DOI":"10.1093\/ndt\/gfn739"},{"key":"5210_CR14","doi-asserted-by":"publisher","unstructured":"Kaplan HM, Deger M, Erdogan KE, Ates T, Demir E (2023) Alpha-linolenic acid protects against methotrexate-induced nephrotoxicity in mouse kidney cells. Eur Rev Med Pharmacol Sci\u00a027(22). https:\/\/doi.org\/10.26355\/eurrev_202311_344793.024","DOI":"10.26355\/eurrev_202311_344793.024"},{"key":"5210_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154935","volume":"118","author":"T Lan","year":"2023","unstructured":"Lan T, Tang T, Li Y, Duan Y, Yuan Q, Liu W, Ren Y, Li N, Liu X, Zhang Y, Li X, Jin G, Wang S, Guo J (2023) FTZ polysaccharides ameliorate kidney injury in diabetic mice by regulating gut-kidney axis. Phytomedicine 118:154935. https:\/\/doi.org\/10.1016\/j.phymed.2023.154935","journal-title":"Phytomedicine"},{"key":"5210_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-3-030-45328-2_5","volume":"1265","author":"X Li","year":"2020","unstructured":"Li X, Zheng S, Wu G (2020) Amino acid metabolism in the kidneys: nutritional and physiological significance. Adv Exp Med Biol 1265:71\u201395. https:\/\/doi.org\/10.1007\/978-3-030-45328-2_5","journal-title":"Adv Exp Med Biol"},{"key":"5210_CR17","unstructured":"Li X, Wu H, Xue G (2024) Exploring the interaction between gut microbiota dysbiosis and chronic kidney disease based on the gut-kidney axis theory. Chin J Clin Res 16(07):137\u2013141. https:\/\/doi.org\/Cnki:Sun:Zyly.0.2024-07-023"},{"key":"5210_CR18","doi-asserted-by":"publisher","unstructured":"Lin C, Dan-Qian C, Jing-Ru L, Jun Z, Nosratola D V, Shougang Z, Hua C, Ya-Long F, Yan G, Ying-Yong Z (2019) Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis. Exp Mol Med 18. https:\/\/doi.org\/10.1038\/s12276-019-0234-2","DOI":"10.1038\/s12276-019-0234-2"},{"key":"5210_CR19","unstructured":"Luo X (2019)\u00a0Effect of Shengqing Jiangzhuo Capsules on CHOP and caspase-12 levels in adenine-induced chronic renal failure rat model [https:\/\/kns.cnki.net\/kcms2\/article\/abstract?v=w3MPIJRjtYHIDflbPdXF_BAUmduuE3hoV0NANYkhsMxbkrvH0KSyqUpMaqo1rynGqyez9UXJyWFhnc4ijkdgVQDf7xVcM_VJ_qtMlaxvrRYnmiP-8Oxk2yyFc09-eRJOibiPOlkj4u8kM76wQySiuC1yQP2eYqFiaRHVZZRs6hpCQq-WKsSnb36JlFh5gifU&uniplatform=NZKPT&language=CHS"},{"key":"5210_CR20","doi-asserted-by":"publisher","unstructured":"Madeleine VP, Nosratola DV (2015) The chronic kidney disease - colonic axis. Semin Dial. https:\/\/doi.org\/10.1111\/sdi.12381","DOI":"10.1111\/sdi.12381"},{"key":"5210_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-025-02793-7","author":"S Mandai","year":"2025","unstructured":"Mandai S (2025) Circulating small extracellular vesicles in chronic kidney disease and vascular calcification: \u201ctiny packages with big biological mission.\u201d Clin Exp Nephrol. https:\/\/doi.org\/10.1007\/s10157-025-02793-7","journal-title":"Clin Exp Nephrol"},{"key":"5210_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04974-6","author":"H Meng","year":"2024","unstructured":"Meng H, Wenqian W, Yichen Z, Zhouxia X, Dan P, Ayijiaken K, Shu R (2024) Gut microbial metabolites SCFAs and chronic kidney disease. J Transl Med. https:\/\/doi.org\/10.1186\/s12967-024-04974-6","journal-title":"J Transl Med"},{"issue":"02","key":"5210_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.13913\/j.cnki.41-1110\/r.2016.02.013","volume":"31","author":"F Pan","year":"2016","unstructured":"Pan F, Tong A (2016) Effect of Shengqing Jiangzhuo Capsules on chronic renal failure and blood TGF-\u03b21 levels. Natl Med Forum 31(02):21\u201322. https:\/\/doi.org\/10.13913\/j.cnki.41-1110\/r.2016.02.013","journal-title":"Natl Med Forum"},{"issue":"1","key":"5210_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00248-022-02081-x","volume":"86","author":"A Pant","year":"2023","unstructured":"Pant A, Maiti TK, Mahajan D, Das B (2023) Human gut microbiota and drug metabolism. Microb Ecol 86(1):97\u2013111. https:\/\/doi.org\/10.1007\/s00248-022-02081-x","journal-title":"Microb Ecol"},{"key":"5210_CR25","doi-asserted-by":"publisher","DOI":"10.34067\/kid.0007502020","author":"M-A Shinobu","year":"2021","unstructured":"Shinobu M-A, Masashi M, Yuji S, Audrey L K, Michel C, Claus K, Makoto M (2021) Free deoxycholic acid exacerbates vascular calcification in CKD through ER stress-mediated ATF4 activation. Kidney360. https:\/\/doi.org\/10.34067\/kid.0007502020","journal-title":"Kidney360"},{"key":"5210_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s10482-016-0737-y","author":"J Shuanghong","year":"2016","unstructured":"Shuanghong J, Shan X, Dan L, Yan Z, Jun D, Lishan Z, Ye C (2016) A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression. Antonie Van Leeuwenhoek. https:\/\/doi.org\/10.1007\/s10482-016-0737-y","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"10","key":"5210_CR27","first-page":"973","volume":"36","author":"F Tao","year":"2019","unstructured":"Tao F, Kong W (2019) Exploring the mechanism of Traditional Chinese Medicine enema in treating chronic kidney disease based on the gut-kidney axis theory. Tianjin J Tradit Chin Med 36(10):973\u2013976","journal-title":"Tianjin J Tradit Chin Med"},{"issue":"2","key":"5210_CR28","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ki.2012.345","volume":"83","author":"ND Vaziri","year":"2013","unstructured":"Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, Ni Z, Nguyen TH, Andersen GL (2013) Chronic kidney disease alters intestinal microbial flora. Kidney Int 83(2):308\u2013315. https:\/\/doi.org\/10.1038\/ki.2012.345","journal-title":"Kidney Int"},{"key":"5210_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-015-0830-1","author":"M Wei","year":"2015","unstructured":"Wei M, Lei Z, Chuan Z, Chuang L, Yifan W, Guobin S, Xinfeng G, Yuchi W, Fuhua L, Qizhan L, Lixin W, Kun B, Peng X, Daixin Z, Yu P, Hui L, Zhaoyu L, Yanxiang G, Xina J, Xusheng L (2015) Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney disease. BMC Complement Altern Med. https:\/\/doi.org\/10.1186\/s12906-015-0830-1","journal-title":"BMC Complement Altern Med"},{"key":"5210_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.554783","author":"Y Wei","year":"2020","unstructured":"Wei Y, Wei Y, Ming-Yan Z, Xiang-Lin M (2020) Functional metabolomics analysis elucidating the metabolic biomarker and key pathway change associated with the chronic glomerulonephritis and revealing action mechanism of rhein. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.554783","journal-title":"Front Pharmacol"},{"issue":"5","key":"5210_CR31","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s13238-020-00814-7","volume":"12","author":"J Wu","year":"2021","unstructured":"Wu J, Wang K, Wang X, Pang Y, Jiang C (2021) The role of the gut microbiome and its metabolites in metabolic diseases. Protein Cell 12(5):360\u2013373. https:\/\/doi.org\/10.1007\/s13238-020-00814-7","journal-title":"Protein Cell"},{"issue":"1","key":"5210_CR32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/13880209.2024.2351946","volume":"62","author":"XQ Wu","year":"2024","unstructured":"Wu XQ, Zhao L, Zhao YL, He XY, Zou L, Zhao YY, Li X (2024) Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota. Pharm Biol 62(1):423\u2013435. https:\/\/doi.org\/10.1080\/13880209.2024.2351946","journal-title":"Pharm Biol"},{"issue":"10","key":"5210_CR33","first-page":"870","volume":"24","author":"B Xie","year":"2024","unstructured":"Xie B, Ren X, Li Z, Gao Y, Ren X (2024) Advances in amino acid metabolomics in kidney disease research. J Clin Nephrol 24(10):870\u2013874","journal-title":"J Clin Nephrol"},{"key":"5210_CR34","unstructured":"Xiong Y (2017)\u00a0Effect of Shengqing Jiangzhuo Capsules on FN and Col-IV expression in adenine-induced chronic renal failure rat model [https:\/\/kns.cnki.net\/kcms2\/article\/abstract?v=w3MPIJRjtYHfDyCIh55ARSFRkaARdjwI96ACSpD1Z8JEJ6c4dyEKHd5mAzmEZhs7zSABqE6oAbJ_cwjruVH1KzYxFyUbNVss_MWtOfvhF-QsISDkoG_YQyp7mQBmyrgcyheQZPUlGscrl1RVQSyZ32MpWoZvZfhj66yTIS2WNYYlCE5BNv0jvTERPnmNDNw&uniplatform=NZKPT&language=CHS"},{"key":"5210_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.889131","author":"Z Yifan","year":"2022","unstructured":"Yifan Z, Haidong H, Yuyan T, Yinshun P, Ping H, Weiqian S, Ping L, Meiping J, Xudong X (2022) Reno-protective effect of low protein diet supplemented with \u03b1-ketoacid through gut microbiota and fecal metabolism in 5\/6 nephrectomized mice. Front Nutr. https:\/\/doi.org\/10.3389\/fnut.2022.889131","journal-title":"Front Nutr"},{"issue":"09","key":"5210_CR36","first-page":"865","volume":"46","author":"J Yu","year":"2021","unstructured":"Yu J, Peng H (2021) Research progress on the relationship between gut microbiota-mediated immune responses, hypertension, and chronic kidney disease. Chin J Mil Med 46(09):865\u2013870","journal-title":"Chin J Mil Med"},{"key":"5210_CR37","doi-asserted-by":"publisher","unstructured":"Yue W, Fei Q, Qiuhua C, Yanting L, Chongxiu Y, Ran B, Xinmeng C, Hongbao Y, Yong Y, Lutz B, Xianjing L, & Xinghua G (2020) Quercetin alleviates acute kidney injury by inhibiting ferroptosis. J Adv Res\u00a028(0). https:\/\/doi.org\/10.1016\/j.jare.2020.07.0076.992","DOI":"10.1016\/j.jare.2020.07.0076.992"},{"key":"5210_CR38","doi-asserted-by":"publisher","unstructured":"Yue L, Jingyi W, Shuo L, Jiawei X, Minggang W, Zhenfang D, & Sheng Q (2023) Guben Xiezhuo Decoction inhibits M1 polarization through the Raf1\/p-Elk1 signaling axis to attenuate renal interstitial fibrosis. J Ethnopharmacol 319(0). https:\/\/doi.org\/10.1016\/j.jep.2023.1171893.69","DOI":"10.1016\/j.jep.2023.1171893.69"},{"key":"5210_CR39","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.biopha.2017.08.115","volume":"95","author":"CY Zhang","year":"2017","unstructured":"Zhang CY, Zhu JY, Ye Y, Zhang M, Zhang LJ, Wang SJ, Song YN, Zhang H (2017) Erhuang formula ameliorates renal damage in adenine-induced chronic renal failure rats via inhibiting inflammatory and fibrotic responses. Biomed Pharmacother 95:520\u2013528. https:\/\/doi.org\/10.1016\/j.biopha.2017.08.115","journal-title":"Biomed Pharmacother"},{"key":"5210_CR40","unstructured":"Zhang X, Fang j, Zhao B, Wu S, Pan Y, Chen Z (2019) Study on the interventional effect and mechanism of Wenyang Xie Zhuo Tong Luo method on renal interstitial fibrosis in chronic renal failure rats. Chin Herb Med 50(09):2133\u20132138. https:\/\/doi.org\/Cnki:Sun:Zcyo.0.2019-09-018"},{"key":"5210_CR41","unstructured":"Zhu X, Chen Z, ZHang Y, Li J, Yan X, Zhao Z, Li T (2020) Experimental study on the effect of Yiqi Huashi Tongluo formula in improving inflammatory fibrosis in chronic renal failure rats by regulating the NF-\u03baB signaling pathway. Chinese Medicinal Herbs 51(08):2193\u20132199. https:\/\/doi.org\/Cnki:Sun:Zcyo.0.2020-08-028"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05210-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05210-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05210-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:43:39Z","timestamp":1783907019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05210-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5210"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05210-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}